{"id":1457,"date":"2018-03-21T20:05:02","date_gmt":"2018-03-22T00:05:02","guid":{"rendered":"https:\/\/www2.law.temple.edu\/10q\/?p=1457"},"modified":"2018-03-21T20:05:02","modified_gmt":"2018-03-22T00:05:02","slug":"opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers","status":"publish","type":"post","link":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/","title":{"rendered":"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers"},"content":{"rendered":"

The Department of Transportation (DOT) recently added four drugs at the heart of the nation’s opioid epidemic to its drug testing panels: hydrocodone, hydromorphone, oxycodone and oxymorphone\u2014the central ingredients in such pain medications as Vicodin, Oxycontin and Percocet. Administrations under the DOT umbrella\u2014including the Federal Aviation Administration, the Pipeline and Hazardous Materials Safety Administration, and the Federal Railroad Administration\u2014now must screen for these four opioids in their employee drug-testing programs. Employees subject to DOT regulations should now be screened for these opioids as part of covered employers’ required drug testing programs.<\/p>\n

Opioid abuse can lead to diminished worker productivity, property damage, workplace injuries, and skyrocketing healthcare costs. Accordingly, employers should consider testing non-DOT covered employees for opioids, at least for safety-sensitive positions. As with any drug testing program, employers need to take steps to ensure that their testing program is legally compliant and the results are used only as permitted by federal and state laws which may control what types of testing are permitted and how the results are used, in addition to protecting employee privacy rights in the testing process. Because opioids may be obtained lawfully with a prescription, unlike many other types of drugs covered by most employers’ drug testing programs, it is particularly important to have careful processes in place for obtaining and evaluating results.<\/p>\n

Under the Americans with Disabilities Act, for example, an employer cannot discriminate against an employee who is using opioids legally with a valid prescription for the treatment of an underlying disability. This determination will require consultation with a medical professional.<\/p>\n

In addition, employers may be required to use a medical review officer to analyze the drug testing results in order to comply with federal law. Even employers not covered by DOT regulations should consider using a medical review officer in the process as a way to best protect employees’ privacy rights and to ensure that the results are used appropriately. Medical review officers analyze the results confidentially and review any positive results with the employees’ treating physicians. Results are reported to employers only if it appears that the employees have been using the drugs illegally or cannot safely perform their job functions\u2014even if the usage is with a valid prescription.<\/p>\n

The opioid crisis affects workers of all ages, ethnicities, and professions. Given the staggeringly high rates of opioid addiction, employers must be prepared for the likelihood that more of their employees are using opioids illegally than they realize. Before they begin drug testing, employers should have protocols in place for working with employees who test positive and decide in what circumstances they will allow for rehabilitation and when disciplinary action is warranted instead.<\/p>\n

A version of this article was originally published here<\/a> by the Ballard Spahr Labor and Employment Group.<\/p>\n

\n

Louis Chodoff<\/a> (LAW \u201988) handles labor and employment law counseling and litigation associated with harassment, discrimination, wage and hour, whistleblower, wrongful discharge, and restrictive covenant disputes.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Ballard Spahr attorney Louis Chodoff (LAW \u201988) discusses the impact of the opioid epidemic on employer drug testing policies.<\/p>\n","protected":false},"author":5,"featured_media":1458,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,70],"tags":[581,582,583,584,585,586,587,588,589,590,591,592,593,594,595,596,597],"coauthors":[2,580],"class_list":["post-1457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alumni-authored","category-labor-and-employment","tag-addiction","tag-americans-with-disabilities-act","tag-department-of-transportation","tag-dot","tag-drug","tag-faa","tag-federal-aviation-administration","tag-federal-railroad-administration","tag-hydrocodone","tag-hydromorphone","tag-medical-review-officers","tag-opioid","tag-oxycodone","tag-oxymorphone","tag-perscription","tag-privacy-rights","tag-testing","masonry-post","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"yoast_head":"\nOpioid Epidemic Spurs Increase in Drug Testing, Risks for Employers - The Temple 10-Q<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers - The Temple 10-Q\" \/>\n<meta property=\"og:description\" content=\"Ballard Spahr attorney Louis Chodoff (LAW \u201988) discusses the impact of the opioid epidemic on employer drug testing policies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/\" \/>\n<meta property=\"og:site_name\" content=\"The Temple 10-Q\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-22T00:05:02+00:00\" \/>\n<meta name=\"author\" content=\"Books Schatschneider, Louis Chodoff (LAW \u201888)\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Books Schatschneider, Louis Chodoff (LAW \u201888)\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/\"},\"author\":{\"name\":\"Books Schatschneider\",\"@id\":\"https:\/\/law.temple.edu\/10q\/#\/schema\/person\/23e7012f0cf133dbeb0e76693c9e0154\"},\"headline\":\"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers\",\"datePublished\":\"2018-03-22T00:05:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/\"},\"wordCount\":498,\"commentCount\":2,\"image\":{\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg\",\"keywords\":[\"Addiction\",\"Americans with Disabilities Act\",\"Department of Transportation\",\"DOT\",\"Drug\",\"FAA\",\"Federal Aviation Administration\",\"Federal Railroad Administration\",\"Hydrocodone\",\"Hydromorphone\",\"Medical Review Officers\",\"Opioid\",\"Oxycodone\",\"Oxymorphone\",\"Perscription\",\"Privacy Rights\",\"Testing\"],\"articleSection\":[\"Alumni Authored\",\"Labor and Employment\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/\",\"url\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/\",\"name\":\"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers - The Temple 10-Q\",\"isPartOf\":{\"@id\":\"https:\/\/law.temple.edu\/10q\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg\",\"datePublished\":\"2018-03-22T00:05:02+00:00\",\"author\":{\"@id\":\"https:\/\/law.temple.edu\/10q\/#\/schema\/person\/23e7012f0cf133dbeb0e76693c9e0154\"},\"breadcrumb\":{\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#primaryimage\",\"url\":\"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg\",\"contentUrl\":\"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/law.temple.edu\/10q\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/law.temple.edu\/10q\/#website\",\"url\":\"https:\/\/law.temple.edu\/10q\/\",\"name\":\"The Temple 10-Q\",\"description\":\"Temple's Business Law Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/law.temple.edu\/10q\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/law.temple.edu\/10q\/#\/schema\/person\/23e7012f0cf133dbeb0e76693c9e0154\",\"name\":\"Books Schatschneider\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/62b6c5fa1068c42262dab498d74cb3fc60fbba8344047dc13348bd3aacf7b70a?s=96&d=mm&r=g9dc77189f33a293d2c82a50cd24ebb9f\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/62b6c5fa1068c42262dab498d74cb3fc60fbba8344047dc13348bd3aacf7b70a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/62b6c5fa1068c42262dab498d74cb3fc60fbba8344047dc13348bd3aacf7b70a?s=96&d=mm&r=g\",\"caption\":\"Books Schatschneider\"},\"url\":\"https:\/\/law.temple.edu\/10q\/author\/rschatsc\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers - The Temple 10-Q","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/","og_locale":"en_US","og_type":"article","og_title":"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers - The Temple 10-Q","og_description":"Ballard Spahr attorney Louis Chodoff (LAW \u201988) discusses the impact of the opioid epidemic on employer drug testing policies.","og_url":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/","og_site_name":"The Temple 10-Q","article_published_time":"2018-03-22T00:05:02+00:00","author":"Books Schatschneider, Louis Chodoff (LAW \u201888)","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Books Schatschneider, Louis Chodoff (LAW \u201888)","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#article","isPartOf":{"@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/"},"author":{"name":"Books Schatschneider","@id":"https:\/\/law.temple.edu\/10q\/#\/schema\/person\/23e7012f0cf133dbeb0e76693c9e0154"},"headline":"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers","datePublished":"2018-03-22T00:05:02+00:00","mainEntityOfPage":{"@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/"},"wordCount":498,"commentCount":2,"image":{"@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#primaryimage"},"thumbnailUrl":"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg","keywords":["Addiction","Americans with Disabilities Act","Department of Transportation","DOT","Drug","FAA","Federal Aviation Administration","Federal Railroad Administration","Hydrocodone","Hydromorphone","Medical Review Officers","Opioid","Oxycodone","Oxymorphone","Perscription","Privacy Rights","Testing"],"articleSection":["Alumni Authored","Labor and Employment"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/","url":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/","name":"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers - The Temple 10-Q","isPartOf":{"@id":"https:\/\/law.temple.edu\/10q\/#website"},"primaryImageOfPage":{"@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#primaryimage"},"image":{"@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#primaryimage"},"thumbnailUrl":"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg","datePublished":"2018-03-22T00:05:02+00:00","author":{"@id":"https:\/\/law.temple.edu\/10q\/#\/schema\/person\/23e7012f0cf133dbeb0e76693c9e0154"},"breadcrumb":{"@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#primaryimage","url":"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg","contentUrl":"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/law.temple.edu\/10q\/opioid-epidemic-spurs-increase-in-drug-testing-risks-for-employers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/law.temple.edu\/10q\/"},{"@type":"ListItem","position":2,"name":"Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers"}]},{"@type":"WebSite","@id":"https:\/\/law.temple.edu\/10q\/#website","url":"https:\/\/law.temple.edu\/10q\/","name":"The Temple 10-Q","description":"Temple's Business Law Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/law.temple.edu\/10q\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/law.temple.edu\/10q\/#\/schema\/person\/23e7012f0cf133dbeb0e76693c9e0154","name":"Books Schatschneider","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/62b6c5fa1068c42262dab498d74cb3fc60fbba8344047dc13348bd3aacf7b70a?s=96&d=mm&r=g9dc77189f33a293d2c82a50cd24ebb9f","url":"https:\/\/secure.gravatar.com\/avatar\/62b6c5fa1068c42262dab498d74cb3fc60fbba8344047dc13348bd3aacf7b70a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/62b6c5fa1068c42262dab498d74cb3fc60fbba8344047dc13348bd3aacf7b70a?s=96&d=mm&r=g","caption":"Books Schatschneider"},"url":"https:\/\/law.temple.edu\/10q\/author\/rschatsc\/"}]}},"jetpack_featured_media_url":"https:\/\/law.temple.edu\/10q\/wp-content\/uploads\/sites\/12\/2018\/03\/pills-384846_1920-2.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/posts\/1457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/comments?post=1457"}],"version-history":[{"count":0,"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/posts\/1457\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/media\/1458"}],"wp:attachment":[{"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/media?parent=1457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/categories?post=1457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/tags?post=1457"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/law.temple.edu\/10q\/wp-json\/wp\/v2\/coauthors?post=1457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}